skinny.

Latest / Unbreakable Vitality

Why Retatrutide May Force Medicine to Rethink Chronic Disease Entirely

What if much of what we call aging is actually metabolic dysfunction accumulating over time?

That reframe is at the center of this episode of Unbreakable Vitality and Retatrutide is the compound that makes it worth having.

Unlike Semaglutide or Tirzepatide, Retatrutide activates three metabolic receptor pathways simultaneously GLP-1, GIP, and glucagon. That third pathway glucagon receptor agonism drives hepatic fat oxidation, thermogenesis, and energy expenditure in ways the earlier generation of drugs couldn't reach. A new multi-omic study published in April 2026 confirms what we've been…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.